Condensed ring compound with sulfur-containing substituent, preparation method, insecticide composition and use

By preparing fused-ring compounds with sulfur substituents, the shortcomings of existing fused bicyclic heterocyclic derivatives in terms of insecticidal and acaricidal activity have been overcome, achieving effective control of a variety of pests and good compatibility with crop plants.

CN115181116BActive Publication Date: 2024-11-26JIANGSU FLAG CHEM IND CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202210906545.3
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2022-07-29
Publication Date
2024-11-26
Estimated Expiration
2042-07-29

AI Technical Summary

Technical Problem

Existing fused bicyclic heterocyclic derivatives have problems with narrow application range or unsatisfactory activity in terms of insecticidal and acaricidal activity, and poor compatibility with crop plants.

Method used

This invention provides a sulfur-substituent fused-ring compound, through specific synthetic steps to prepare a novel fused bicyclic heterocyclic derivative with excellent biological and environmental properties, which can be used to prepare insecticides and acaricides. The specific synthetic method includes multi-step organic reactions, such as acetic acid reflux, ethanethiol contact under alkaline conditions, oxidant reaction, Buchwald coupling, etc.

Benefits of technology

It exhibits good control effects against a variety of pests at low concentrations, providing a basis for the research and development of new pesticides, and has good compatibility with crops and plants.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN115181116B_ABST
    Figure CN115181116B_ABST
Patent Text Reader

Abstract

The present invention belongs to the field of agricultural pesticides, and specifically relates to a condensed ring compound containing a sulfur substituent, a preparation method, a pesticide composition and use. Compared with the prior art, the beneficial effect of the present invention is that the condensed ring compound containing a sulfur substituent provided by the present invention has a good control effect on a variety of pests at a relatively low test concentration, which provides a basis for the research and development of new pesticides. #imgabs0#
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the field of agricultural pesticides, and in particular to a condensed ring compound containing a sulfur substituent, a preparation method, a pesticide composition and use. Background Art

[0002] Fused bicyclic heterocyclic derivatives with insecticidal properties have been described in the following documents: for example, WO2014 / 119672A1, WO2015 / 002211A1, WO2017 / 026384A1, WO2018 / 015289A1, WO2016 / 091731A1. However, some of the active compounds known from the above documents have disadvantages when used, either because they have only a narrow application range or because they do not have satisfactory insecticidal or acaricidal activity.

[0003] Novel fused bicyclic heterocyclic derivatives have been found which have advantages over known compounds, such as better biological or environmental properties, more application methods, better insecticidal or acaricidal action, and good compatibility with crop plants. The fused bicyclic heterocyclic derivatives can be used in combination with other agents for improved efficacy, in particular against difficult-to-control insects.

[0004] The present invention provides a fused heterocyclic compound containing a sulfur substituent, a fused bicyclic heterocyclic derivative of a new structure, and a preparation method and an intermediate used for the preparation thereof. The present invention also provides an insecticide, and uses the compound as an acaricide and / or insecticide for controlling animal pests, especially arthropods, and especially insects and arachnids. Summary of the invention

[0005] The technical problem to be solved by the present invention is to provide a first object of the present invention is to provide a class of condensed ring compounds containing sulfur substituents as shown in the general formula (I):

[0006]

[0007] In the formula

[0008] X is selected from N, NR1, O or S;

[0009] Y is selected from N or S;

[0010] Wherein when Y is selected from N, X is selected from NR1, O or S; when Y is selected from S, X is selected from N;

[0011] Wherein R1 is selected from H, C 1~6 Alkyl, C 1~6 Haloalkyl, C 3~6 Cycloalkyl, C 3~6 Halogenated cycloalkyl; wherein R is selected from C 1~6Alkyl, C 1~6 Substituted alkyl, C 3~6 Cycloalkyl, C 3~6 Substituted cycloalkyl, C 2~6 Epoxy, C 2~6 Alkenyl, C 2~6 Alkynyl, phenyl, substituted phenyl, C 5~6 Heterocyclic or substituted heterocyclic ring;

[0012] The substituents of the substituted alkyl or substituted cycloalkyl are selected from halogen, C 1~2 Alkyl, C 1~2 Alkoxy, C 1~2 Halogenated alkoxy, C 1~2 A haloalkyl group, a cyano group or an ester group;

[0013] The substituted phenyl group refers to a phenyl group having 1, 2 or 3 substituents, wherein the substituents are selected from halogen, C 1~2 Alkoxy, C 1~2 Haloalkoxy, cyano, C 1~6 Alkyl or C 1~6 Haloalkyl;

[0014] The heterocyclic ring is selected from a five-membered or six-membered monocyclic ring having at least one non-carbon ring atom, including aromatic rings and non-aromatic hydrocarbons;

[0015] The substituted heterocycle refers to a heterocycle having 1, 2 or 3 substituents, wherein the substituents of the substituted heterocycle are selected from halogen, C 1~6 Alkyl, C 1~6 Haloalkyl, C 1~6 Alkoxy or C 1~6 Alkylamide.

[0016] Preferably, the R1 is selected from H, C 1~6 Alkyl, trifluoromethyl or cyclopropyl;

[0017] R is selected from C 1~6 Alkyl, C 1~6 Haloalkyl, C 3~6 Cycloalkyl, C 2~6 Alkenyl, C 2~6 Alkynyl, phenyl, substituted phenyl, C 5~6 Heterocyclic or substituted heterocyclic ring;

[0018] The substituted phenyl group refers to a phenyl group having 1, 2 or 3 substituents, wherein the substituents are selected from halogen, C 1~2 Alkoxy, C 1~2 Haloalkoxy, cyano, C 1~2 Alkyl or C 1~2 Haloalkyl;

[0019] The heterocycle is selected from a five-membered nitrogen-containing heterocycle, a five-membered sulfur-containing heterocycle, a five-membered oxygen-containing heterocycle, a six-membered nitrogen-containing heterocycle, a six-membered sulfur-containing heterocycle or a six-membered oxygen-containing heterocycle;

[0020] The substituents of the substituted heterocyclic ring are selected from halogen, C 1~2 Alkyl, C 1~2 Haloalkyl, C 1~2 Alkoxy or C 1~2 Alkylamide.

[0021] More preferably, R1 is selected from C 1~4 alkyl;

[0022] R is selected from C 1~6 Alkyl, C 1~6 Haloalkyl, C 3~6 Cycloalkyl, C 2~6 Alkenyl, C 2~6 Alkynyl, phenyl, substituted phenyl, C 5~6 Heterocyclic or substituted heterocyclic ring;

[0023] The substituted phenyl group refers to a phenyl group having 1, 2 or 3 substituents, wherein the substituents are selected from halogen, methoxy, cyano, ethoxy, methyl, ethyl or trifluoromethyl;

[0024] The heterocyclic ring is selected from piperazinyl, pyrrolidinyl, dioxanyl, morpholinyl, tetrahydrofuranyl, pyridyl, furanyl, imidazolyl, pyrimidinyl, oxazolyl, isoxazolyl, tetrazolyl, triazolyl, thiadiazolyl and thienyl;

[0025] The substituted heterocycle refers to a heterocycle having 1, 2 or 3 substituents, and the substituents of the substituted heterocycle are selected from halogen, methyl, ethyl, methoxy, trifluoromethyl or difluoromethyl.

[0026] Further preferably, R1 is selected from methyl;

[0027] R is selected from C1-C6 alkyl, C1-C6 haloalkyl, C3-C6 cycloalkyl, C2-C6 alkenyl, C2-C6 alkynyl, phenyl, substituted phenyl, C5-C6 heterocycle or substituted heterocycle;

[0028] The substituted phenyl group refers to a phenyl group having 1, 2 or 3 substituents, wherein the substituents are selected from halogen, methoxy, cyano, methyl or trifluoromethyl;

[0029] The heterocyclic ring is selected from 2-thienyl, pyridyl, 2-chloropyridyl or 5-bromopyridyl;

[0030] The substituted heterocycle refers to a heterocycle having 1, 2 or 3 substituents, and the substituents of the substituted heterocycle are selected from halogen, methyl, methoxy or trifluoromethyl.

[0031] Still further preferably, R is selected from methyl, trifluoromethyl, difluoromethyl, chloromethyl, cyclopropyl, heptafluoroisopropyl, ethyl, chloromethyl, isopropyl, n-propyl, isobutyl, tert-butyl, cyclobutyl, cyclopentyl, cyclohexyl, vinyl, ethynyl, propenyl, butenyl, propynyl, butynyl, phenyl, cyanocyclopropyl, 4-fluorophenyl, 2-fluorophenyl, 3-fluorophenyl, 2,4-difluorophenyl, 2-thienyl, 2-pyridyl, 2-chloropyridyl or 5-bromopyridyl.

[0032] More preferably, R1 is selected from methyl; R is selected from cyclopropyl or trifluoromethyl.

[0033] In a preferred embodiment of the present invention, compounds of formula (Ia), (Ib), (Ic) and (Id) are provided:

[0034]

[0035] R1 is selected from methyl; R is selected from methyl, trifluoromethyl, difluoromethyl, cyclopropyl, heptafluoroisopropyl, ethyl, chloromethyl, isopropyl, n-propyl, isobutyl, tert-butyl, cyclobutyl, cyclopentyl, cyclohexyl, vinyl, ethynyl, propenyl, butenyl, propynyl, butynyl, phenyl, cyanocyclopropyl, 4-fluorophenyl, 2-fluorophenyl, 3-fluorophenyl, 2,4-difluorophenyl, 2-thienyl, 2-pyridyl, 2-chloropyridyl or 5-bromopyridyl.

[0036] More preferably, R1 is selected from methyl; R is selected from cyclopropyl or trifluoromethyl.

[0037] As a preferred specific compound structure of the present invention, its substituents are shown in Table 1 (based on general formula I):

[0038] Table 1

[0039]

[0040]

[0041]

[0042] and N-oxides or tautomers of the compounds of Table 1. "Ph" represents a phenyl group, and "Py" represents a pyridine group.

[0043] The second object of the present invention is to provide a method for preparing a condensed ring compound containing a sulfur substituent, taking the structure shown in (Ia) as an example, comprising the following steps:

[0044]

[0045] (1) stirring and refluxing the compound obtained by reacting the compound of formula (II) with the compound of formula (III) in acetic acid to obtain the compound of formula (IV); the preparation of the compound of formula (II) is well known and has been described in, for example, WO 2014 / 119672A and WO 2015 / 002211A; the compound of formula (III) can be prepared by commercially available 3-chloro-5-bromopyridine-2-carboxylic acid;

[0046] (2) contacting the compound represented by formula (IV) with ethanethiol under alkaline conditions to obtain the compound represented by formula (V);

[0047] (3) reacting the compound represented by formula (V) with an oxidant to obtain the compound represented by formula (VI);

[0048] (4) reacting the compound represented by formula (VI) with 2,4-dimethoxybenzylamine through a Buchwald coupling reaction to obtain a compound represented by formula (VII);

[0049] (5) reacting the compound represented by formula (VII) with trifluoroacetic acid to obtain the compound represented by formula (VIII);

[0050] (6) contacting the compound represented by formula (VIII) with a brominating agent to obtain a compound represented by formula (IX);

[0051] (7) reacting the compound represented by formula (IX) with an acid chloride in the presence of an acid binding agent to obtain a compound represented by formula (X);

[0052] (8) reacting the compound represented by formula (X) with Lawesson's reagent to obtain a compound represented by formula (XI);

[0053] (9) reacting the compound represented by formula (XI) in the presence of a base to obtain the final target compound represented by formula (Ia); wherein R and R1 are as described above, but are not limited to the present invention;

[0054]

[0055] Preferably, the organic solvent in step (1) is selected from one or more of acetic acid, benzene and toluene, preferably acetic acid; the reaction temperature is 25 to 110° C., preferably 110° C.; the volume of the organic solvent used is 0.3 to 9 mL / mmol, preferably 0.4 mL / mmol, based on the molar amount of the compound represented by formula (II).

[0056] Preferably, the organic solvent used in step (2) is one or more of benzene, toluene, DMF or tetrahydrofuran, preferably tetrahydrofuran; the base is one or more of sodium hydride, sodium hydroxide and potassium hydroxide, preferably sodium hydride; the molar ratio of the compound represented by formula (IV) to ethanethiol and sodium hydride is 1:1-2:1-2, preferably 1:1:1.2; the reaction temperature is -10-80°C, preferably 0°C; the volume amount of the organic solvent is 0.3-9 mL / mmol, preferably 5 mL / mmol, based on the molar amount of the compound represented by formula (IV).

[0057] Preferably, the organic solvent used in step (3) is one or more of dichloromethane, dichloroethane, methanol, ethanol, DMF, and tetrahydrofuran, preferably dichloromethane; the oxidant is one or more of hydrogen peroxide and m-chloroperbenzoic acid, preferably hydrogen peroxide. The reaction temperature is 25 to 40°C, preferably 25°C; the volume of the organic solvent is 0.3 to 9 mL / mmol, preferably 5 mL / mmol, based on the molar amount of the compound represented by formula (V).

[0058] Preferably, the organic solvent used in step (4) is one or more of benzene, toluene, and 1,4-dioxane, preferably toluene. The reaction temperature is 25 to 150° C., preferably 120° C.; the volume of the organic solvent is 0.3 to 9 mL / mmol, preferably 5 mL / mmol, based on the molar amount of the compound represented by formula (VI).

[0059] Preferably, the organic solvent used in step (5) is one or more of dichloromethane, dichloroethane, ethanol, methanol, acetonitrile and tetrahydrofuran, preferably dichloromethane; the reaction temperature is 25 to 80°C, preferably 25°C; the molar ratio of the compound represented by formula (VII) to trifluoroacetic acid is 1:1 to 10, preferably 1:2; the volumetric amount of the organic solvent is 3 to 9 mL / mmol, preferably 5 mL / mmol, based on the molar amount of the compound represented by formula (VII).

[0060] Preferably, the organic solvent in step (6) is one or more of dichloromethane, dichloroethane, tetrahydrofuran, toluene, 1,4-dioxane, and acetic acid, preferably acetic acid; the bromination reagent is one or more of bromine and NBS, preferably bromine; the reaction temperature is 25 to 80° C., preferably 80° C.; the volume amount of the organic solvent is 3 to 9 mL / mmol, preferably 5 mL / mmol, based on the molar amount of the compound represented by formula (VIII).

[0061] Preferably, the organic solvent in step (7) is selected from one or more of dichloromethane, dichloroethane, tetrahydrofuran, N,N-dimethylformamide or acetonitrile, preferably tetrahydrofuran; the acid binding agent is one or more of triethylamine, potassium carbonate, sodium carbonate, potassium hydroxide, sodium hydroxide, pyridine, DMAP or sodium hydride, preferably triethylamine; the reaction temperature is 0 to 80° C., preferably 25° C. The volume amount of the organic solvent is 3 to 9 mL / mmol, preferably 5 mL / mmol, based on the molar amount of the compound represented by formula (IX).

[0062] Preferably, the organic solvent in step (8) is selected from one or more of dichloromethane, dichloroethane, tetrahydrofuran, N,N-dimethylformamide or acetonitrile, preferably tetrahydrofuran; the molar ratio of the compound represented by formula (X) to Lawesson's reagent is 1:1-5, preferably 1:1.5; the reaction temperature is 25-80°C, preferably 80°C; the volumetric amount of the organic solvent is 3-9 mL / mmol, preferably 5 mL / mmol, based on the molar amount of the compound represented by formula (X).

[0063] Preferably, the organic solvent in step (9) is selected from one or more of dichloromethane, dichloroethane, tetrahydrofuran, N,N-dimethylformamide or acetonitrile, preferably N,N-dimethylformamide; the base is one or more of sodium hydride, sodium carbonate, potassium carbonate, sodium hydroxide, potassium hydroxide, preferably sodium hydride; the reaction temperature is 25 to 120° C., preferably 110° C.; the volume amount of the organic solvent is 3 to 9 mL / mmol, preferably 5 mL / mmol, based on the molar amount of the compound represented by formula (XI).

[0064]

[0065] A similar preparation of the structure shown in (Ib) comprises the following steps:

[0066] The compound represented by formula (X) is refluxed and stirred in a solvent in the presence of CuI, a base and a catalyst to prepare the compound represented by formula (Ib).

[0067]

[0068] Preferably, in the above steps, the catalyst is 10-phenanthroline; the base is one or more of sodium carbonate, potassium carbonate, and cesium carbonate, preferably cesium carbonate; the solvent is one or more of tetrahydrofuran, dichloromethane, dichloroethane, and ethylene glycol dimethyl ether, preferably ethylene glycol dimethyl ether; the volume amount of the organic solvent is 3 to 9 mL / mmol, preferably 5 mL / mmol, based on the molar amount of the compound represented by formula (X).

[0069]

[0070] A similar preparation of the structure shown in (Ic) comprises the following steps:

[0071] (1) The same as the method for preparing formula (IV) in (Ia), the compound represented by formula (II) is refluxed and stirred in acetic acid to obtain the compound represented by formula (III);

[0072] (2) reacting the compound represented by formula (III) with ethanethiol in the presence of a base to obtain a compound represented by formula (IV);

[0073] (3) The compound represented by formula (IV) is oxidized to obtain the compound represented by formula (V);

[0074] (4) contacting the compound represented by formula (V) with a substituted amine in a solvent to obtain a compound represented by formula (VI);

[0075] (5) dissolving the compound represented by formula (VI) in concentrated sulfuric acid, and then adding dilute nitric acid dropwise at low temperature to obtain the compound represented by formula (VII);

[0076] (6) The compound represented by formula (VII) is reduced to obtain the compound represented by formula (VIII);

[0077] (7) The preparation of formula (IX) is the same as the preparation of formula (X) in (Ia);

[0078] (8) The compound represented by formula (IX) is refluxed and stirred in acetic acid to finally prepare the compound represented by formula (Ic).

[0079]

[0080] Preferably, the organic solvent in step (1) is selected from one or more of acetic acid, benzene and toluene, preferably acetic acid; the reaction temperature is 25 to 110° C., preferably 110° C.; the volume of the organic solvent used is 0.3 to 9 mL / mmol, preferably 0.4 mL / mmol, based on the molar amount of the compound represented by formula (II).

[0081] Preferably, the organic solvent used in step (2) is one or more of benzene, toluene, DMF or tetrahydrofuran, preferably tetrahydrofuran; the base is one or more of sodium hydride, sodium hydroxide and potassium hydroxide, preferably sodium hydride; the molar ratio of the compound represented by formula (IV) to ethanethiol and sodium hydride is 1:1-2:1-2, preferably 1:2:2; the reaction temperature is -10-80°C, preferably 0°C; the volume amount of the organic solvent is 0.3-9 mL / mmol, preferably 5 mL / mmol, based on the molar amount of the compound represented by formula (IV).

[0082] Preferably, the organic solvent used in step (3) is one or more of dichloromethane, dichloroethane, methanol, ethanol, DMF, and tetrahydrofuran, preferably dichloromethane; the oxidant is one or more of hydrogen peroxide and m-chloroperbenzoic acid, preferably hydrogen peroxide. The reaction temperature is 25 to 40°C, preferably 25°C; the volume of the organic solvent is 0.3 to 9 mL / mmol, preferably 5 mL / mmol, based on the molar amount of the compound represented by formula (V).

[0083] Preferably, the solvent used in step (4) is one or more of methanol, ethanol, DMF or tetrahydrofuran, preferably tetrahydrofuran; the reaction temperature is 25-120°C, preferably 100°C.

[0084] Preferably, the reaction temperature in step (5) is -10 to 25°C, preferably 0°C.

[0085] Preferably, in step (6), the reducing agent is iron powder or palladium carbon, preferably palladium carbon.

[0086] Preferably, the organic solvent in step (7) is selected from one or more of dichloromethane, dichloroethane, tetrahydrofuran, N,N-dimethylformamide or acetonitrile, preferably tetrahydrofuran; the acid binding agent is one or more of triethylamine, potassium carbonate, sodium carbonate, potassium hydroxide, sodium hydroxide, pyridine, DMAP or sodium hydride, preferably triethylamine; the reaction temperature is 0 to 80°C, preferably 25°C. The volume amount of the organic solvent is 3 to 9 mL / mmol, preferably 5 mL / mmol, based on the molar amount of the compound represented by formula (VIII);

[0087] Preferably, the reaction temperature in step (8) is 90-150°C, preferably 110°C.

[0088]

[0089] A similar preparation of the structure shown in (Id) comprises the following steps:

[0090] (1) contacting the compound of formula (V) prepared in (Ic) with aqueous ammonia in a solvent to prepare a compound represented by formula (X);

[0091] (2) subjecting the compound represented by formula (X) to a bromination reaction in a solvent in the presence of a base to obtain a compound represented by formula (XI);

[0092] (3) The preparation of formula (XII) is the same as the preparation of formula (IX) in (Ic);

[0093] (4) The preparation of formula (XIII) is the same as the preparation of formula (XI) in (Ia);

[0094] (5) The preparation of formula (Id) is the same as that of formula (Ia).

[0095]

[0096] Preferably, the solvent used in step (1) is one or more of methanol, ethanol, DMF or tetrahydrofuran, preferably tetrahydrofuran; the reaction temperature is 25-120°C, preferably 100°C.

[0097] Preferably, the organic solvent in step (2) is one or more of dichloromethane, dichloroethane, tetrahydrofuran, toluene, 1,4-dioxane, and acetic acid, preferably acetic acid; the bromination reagent is one or more of bromine and NBS, preferably bromine; the base is sodium acetate or potassium acetate, preferably potassium acetate; the reaction temperature is 25 to 80° C., preferably 80° C.; the volume amount of the organic solvent is 3 to 9 mL / mmol, preferably 5 mL / mmol, based on the molar amount of the compound represented by formula (VIII).

[0098] Preferably, the organic solvent in step (3) is selected from one or more of dichloromethane, dichloroethane, tetrahydrofuran, N,N-dimethylformamide or acetonitrile, preferably tetrahydrofuran; the acid binding agent is one or more of triethylamine, potassium carbonate, sodium carbonate, potassium hydroxide, sodium hydroxide, pyridine, DMAP or sodium hydride, preferably triethylamine; the reaction temperature is 0 to 80° C., preferably 25° C. The volume amount of the organic solvent is 3 to 9 mL / mmol, preferably 5 mL / mmol, based on the molar amount of the compound represented by formula (XI).

[0099] Preferably, in the step (4), the organic solvent is selected from one or more of dichloromethane, dichloroethane, tetrahydrofuran, N,N-dimethylformamide or acetonitrile, preferably tetrahydrofuran; the molar ratio of the compound represented by formula (XII) to Lawesson's reagent is 1:1-5, preferably 1:1.5; the reaction temperature is 25-80°C, preferably 80°C; the volumetric amount of the organic solvent is 3-9 mL / mmol, preferably 5 mL / mmol, based on the molar amount of the compound represented by formula (XII).

[0100] Preferably, in step (5), the organic solvent is selected from one or more of dichloromethane, dichloroethane, tetrahydrofuran, N,N-dimethylformamide or acetonitrile, preferably N,N-dimethylformamide; the base is one or more of sodium hydride, sodium carbonate, potassium carbonate, sodium hydroxide, potassium hydroxide, preferably sodium hydride; the reaction temperature is 25 to 120° C., preferably 110° C.; the volume amount of the organic solvent is 3 to 9 mL / mmol, preferably 5 mL / mmol, based on the molar amount of the compound represented by formula (XIII).

[0101] The third aspect of the present invention provides a use of a condensed ring compound containing a sulfur substituent as shown in formula (I) in the preparation of an insecticide.

[0102] Preferably, the insecticide is an insecticide for controlling Lepidoptera and / or Coleoptera; further, the pests may be one or more of brown planthopper, gray planthopper, whitefly, diamondback moth, armyworm, green peach aphid, and spider mite.

[0103] The fourth aspect of the present invention provides an insecticide, which includes a condensed ring compound containing a sulfur substituent and an auxiliary agent, wherein the concentration of the condensed ring compound containing a sulfur substituent in the insecticide is 1 to 600 ppm; further, the concentration of the condensed ring compound containing a sulfur substituent in the insecticide is 4 to 100 ppm.

[0104] If there is any conflict between the Chinese name and the structural formula of the compound in the present invention, the structural formula shall prevail.

[0105] Compared with the prior art, the beneficial effect of the present invention is that the condensed ring compound containing sulfur substituents provided by the present invention has good control effects on various pests at a relatively low test concentration, thus providing a basis for the research and development of new pesticides. DETAILED DESCRIPTION

[0106] The present invention is described below with reference to examples, but the present invention is not limited thereto. In the art, simple replacement or improvement made by technicians in the field to the present invention belongs to the technical solution protected by the present invention.

[0107] Preparation Example 1:

[0108] Synthesis of target compound I-1

[0109]

[0110] Step A: Synthesis of 2-methylamino-5-trifluoromethylpyridine

[0111]

[0112] 2-Chloro-5-trifluoromethylpyridine (90.5 g, 0.5 mol) was dissolved in acetonitrile (50 mL), and methylamine alcohol solution (46.5 g, 1.5 mol) was added thereto. The mixed solution was stirred overnight at 100 degrees in a 350 mL pressure bottle. The reaction end point was monitored by TLC and LCMS. The reaction mixture was then concentrated in vacuo to give white crystals, i.e. 2-methylamino-5-trifluoromethylpyridine, in a yield of 95%.

[0113] Step B: Synthesis of 2-methylamino-3-nitro-5-trifluoromethylpyridine

[0114]

[0115] 2-Methylamino-3-nitro-5-trifluoromethylpyridine (52.8 g, 0.3 mol) was dissolved in concentrated sulfuric acid (100 mL), and nitric acid (18.9 g, 0.3 mol) was added dropwise under ice bath conditions. After the addition was completed within 30 minutes, the ice bath was removed, and the reaction solution was heated to 80 degrees for 3 hours. The reaction end point was monitored by LC and GC-MS. The reaction solution was then slowly poured into ice water to precipitate solids, filtered and washed, and the filter cake was dried to give 47.7 g of the title compound as a yellow solid, with a yield of 72%.

[0116] Step C: Synthesis of 2-methylamino-3-amino-3-trifluoromethylpyridine

[0117]

[0118] 2-Methylamino-3-nitro-5-trifluoromethylpyridine (11.05 g, 50 mmol) was dissolved in tetrahydrofuran (100 mL), 5% Pd / C was added thereto, hydrogen was introduced thereto, and the mixture was stirred at room temperature for 24 hours. TLC and GC-MS were used to monitor the end point of the reaction. The reaction solution was then filtered to remove palladium on carbon, and the filtrate was concentrated in vacuo to give the title compound as reddish brown crystals, 10.9 g, in a yield of 99%.

[0119] Step D: Synthesis of 3,6-dichloropyridine-2-carbonyl chloride

[0120]

[0121] A sample of 3,6-dichloropyridine-2-carboxylic acid (5.00 g, 24.7 mmol) was diluted in dichloromethane (200 mL) and dimethylformamide (0.124 mL, 1.6 mmol) was added. Oxalyl chloride (3.15 mL, 34.6 mmol) was added dropwise to the solution at room temperature over 10 minutes (gas evolution). The reaction mixture was stirred at room temperature and an additional 1 mL of oxalyl chloride was added after 2.5 hours and stirring was continued for 1 hour. After this time, the reaction mixture was concentrated in vacuo and used in the next step without further purification.

[0122] Step E: Synthesis of 3,6-dichloro-N-(2-(methylamino)-5-(trifluoromethyl)pyridin-3-yl)picolinamide

[0123]

[0124] Et 3N (22.32 g, 218.4 mmol) was added to a solution of 2-methylamino-3-amino-3-trifluoromethylpyridine (16.70 g, 87.37 mmol) in THF (167.0 mL). The reaction mixture was cooled to 0 ° C, and 3,6-dichloropyridine-2-carbonyl chloride (18.37 g, 87.37 mmol) dissolved in dichloromethane (170 mL) was added dropwise to the mixture at 0-10 ° C for 1 hour. After 1.5 hours, the desired product was detected by LC-MS. The ice bath was removed, and the reaction mixture was allowed to warm to ambient temperature and stirred for 12 hours. The reaction mixture was then diluted with saturated NH 4 Cl, the organic phase was separated, and the aqueous phase was stripped with dichloromethane. The combined organic phase was washed with water, brine, dried over Na 2 SO 4, filtered and concentrated in vacuo to give a crude product. The crude product was purified by column chromatography.

[0125] Step F: Synthesis of 2-(3,6-dichloropyridin-2-yl)-3-methyl-6-(trifluoromethyl)-3H-imidazo[4,5-b]pyridine

[0126]

[0127] A yellow solution of 3,6-dichloro-N-(2-(methylamino)-5-(trifluoromethyl)pyridin-3-yl)picolinamide (15.6 g, 42.75 mmol) in acetic acid (50 mL) was stirred overnight at a bath temperature of 110°C. LC-MS analysis showed that the reaction was complete. The reaction solution was then poured into ice water, extracted with EA (20 mL*3), the organic phases were combined, washed with saturated sodium bicarbonate solution (20 mL*3), dried over Na2SO4, and purified by column chromatography to obtain 8 g of a white solid. The crude yield was 54%.

[0128] Step G: Synthesis of 2-(6-chloro-3-(ethylthio)pyridin-2-yl)-3-methyl-6-(trifluoromethyl)-3H-imidazo[4,5-b]pyridine

[0129]

[0130] 2-(3,6-dichloropyridin-2-yl)-3-methyl-6-(trifluoromethyl)-3H-imidazo[4,5-b]pyridine (1.14 g, 3.28 mmol) was dissolved in tetrahydrofuran. NaH (3.28 mmol) was added in batches at room temperature, and ethanethiol (0.2 g, 3.28 mmol) was added dropwise after stirring for 30 minutes, and stirred at room temperature until the reaction was completed. The reaction mixture was treated with NH4Cl and then extracted with ethyl acetate. The organic layer was separated, washed with water and brine, dried over Na2SO4, and the crude product was purified by flash chromatography on silica gel to obtain the title compound as a beige solid. The yield was 80%.

[0131] Step H: Synthesis of 2-(6-chloro-3-(ethylsulfonyl)pyridin-2-yl)-3-methyl-6-(trifluoromethyl)-3H-imidazo[4,5-b]pyridine

[0132]

[0133] The product obtained in the previous step (8.556g, 23mmol) was added with formic acid (5.29g, 115mmol) and hydrogen peroxide (3.0g, 161mmol) at room temperature, and then the mixture was stirred at room temperature for 5 hours. After the reaction was completed, it was diluted with water, sodium bisulfite solution was added and stirred for one hour, and then saturated sodium bicarbonate solution was added. The organic phase was separated, the aqueous phase was extracted twice with dichloromethane, the organic phases were combined, dried over anhydrous sodium sulfate, and purified by column chromatography to obtain 6.6g of white solid with a yield of 74.5%.

[0134] Step I: 5-(Ethylsulfonyl)-6-(3-methyl-6-(trifluoromethyl)-3H-imidazo[4,5-b]pyridin-2-yl)pyridin-2-amine

[0135]

[0136] Dissolve 2-(6-chloro-3-(ethylsulfonyl)pyridin-2-yl)-3-methyl-6-(trifluoromethyl)-3H-imidazo[4,5-b]pyridine (0.4 g, 1 mmol) in ethanol. Add the above solution to a pressure bottle, add 3 equivalents of ammonia water, and react at 120 degrees overnight. LC-MS shows that the reaction is complete. Cool the solution to room temperature, solid precipitates, filter and wash with a small amount of methanol. Dry to obtain a yellow solid. Yield 90%.

[0137] Step J: 5-(Ethylsulfonyl)-6-(3-methyl-6-(trifluoromethyl)-3H-imidazo[4,5-b]pyridin-2-yl)pyridine-2-methanamine

[0138]

[0139] The compound obtained in step H was dissolved in methanol, and then 3 times the methylamine alcohol solution was added, and the mixture was reacted overnight at 120 degrees in a pressure bottle. After the reaction was completed by LC-MS monitoring, the reaction solution was cooled to room temperature. At this time, a solid was precipitated, and the solid was filtered out and dried to obtain the product.

[0140] 1 H NMR(400MHz,Chloroform-d)δ8.73(d,J=1.9Hz,1H),8.28(d,J=2.0Hz,1H),8.10(d,J=9.0Hz,1H),6.60(d,J =8.9Hz,1H),5.30(s,1H),3.86(s,3H),3.60(q,J=7.4Hz,2H),3.03(d,J=5.1Hz,3H),1.31(t,J=7.4Hz,3H).

[0141] Step K: Synthesis of 5-(ethylsulfonyl)-N-methyl-6-(3-methyl-6-(trifluoromethyl)-3H-imidazo[4,5-b]pyridin-2-yl)-3-nitro-2-amine

[0142]

[0143] The compound obtained in step J was dissolved in concentrated sulfuric acid, and then an equivalent amount of nitric acid was added dropwise under an ice bath. After the addition was complete, the mixture was stirred at room temperature for several hours. After the reaction was completed as monitored by LC-MS, the reaction solution was poured into ice water to precipitate a yellow solid, which was filtered out, dried, and used directly in the next reaction without purification.

[0144] Step L: 5-(Ethylsulfonyl)-N 2 Synthesis of 6-(3-methyl-6-(trifluoromethyl)-3H-imidazo[4,5-b]pyridin-2-yl)pyridine-2,3-diamine

[0145]

[0146] The crude product obtained in step K is dissolved in THF, and then a palladium carbon catalyst of 5% of the raw material mass is added thereto, and the air in the bottle is replaced with hydrogen for 3 times, and then stirred at 30 degrees for overnight reaction. After LC-MS monitoring shows that the reaction is complete, the reaction liquid is filtered, the filtrate is spin-dried, and the obtained crude product can be purified by column chromatography.

[0147] Step M: Synthesis of target compound I-1

[0148]

[0149] The compound obtained in step L (1 mmol) was dissolved in THF, and then cyclopropanecarbonyl chloride (1 mmol) and triethylamine (1.5 mmol) were added thereto. The mixture was stirred at room temperature. After the reaction was completed, the reaction solution was directly spin-dried and then dissolved in acetic acid, and refluxed at 120°C for several hours. After the reaction was completed by LC-MS detection, water was added to the reaction solution, extracted with ethyl acetate, and then the organic phase was dried and purified by column chromatography to obtain 109 mg of the title compound, with a two-step yield of 20%, and mp 201-204°C.

[0150] 1 H NMR (400MHz, CDCl3) δ8.79–8.74(m,1H),8.65(s,1H),8.31(d,J=2.0Hz,1H),3.99(s,3H),3.83(s,3H),3.68( q,J=7.4Hz,2H),2.14(tt,J=8.1,4.8Hz,1H),1.42(dt,J=4.8,3.2Hz,2H),1.35–1.28(m,5H).EI-MS:465[M+H] +

[0151] Preparation Example 2:

[0152] According to the method described in step M of Preparation Example 1, acetyl chloride is used to replace cyclopropanecarbonyl chloride to prepare the compound I-2 of the present invention represented by the following formula.

[0153]

[0154] Compound I-2 of the present invention

[0155] 1 H NMR (400MHz, CDCl3) δ8.79–8.73(m,2H),8.33(d,J=2.0Hz,1H),3.89(s,3H),3.82(s,3H),3.68(q,J=7.5Hz,2H),2.79(s,3H),1.33(t,J=7.4Hz,3H).

[0156] Preparation Example 3:

[0157] Synthesis of target compound I-73

[0158]

[0159] Step A: Synthesis of intermediate compound 1

[0160] According to the method described in Step E of Preparation Example 1, the intermediate compound 1 represented by the following formula can be obtained by replacing 3,6-dichloropyridine-2-carbonyl chloride with 3-chloro-5-bromopyridine-2-carbonyl chloride.

[0161]

[0162] Intermediate compound 1

[0163] 1 H NMR (400MHz, CDCl3) δ9.33 (s, 1H), 8.60 (d, J = 1.9Hz, 1H), 8.36 (dd, J = 2.2, 1.1Hz, 1H), 8. 10(d,J=1.9Hz,1H),7.86(d,J=2.1Hz,1H),5.03(d,J=5.9Hz,1H),3.08(d,J=4.8Hz,3H).

[0164] Step B: Synthesis of intermediate compound 2

[0165] According to the method described in Step F of Preparation Example 1, an intermediate compound 2 represented by the following formula can be obtained.

[0166]

[0167] Intermediate compound 2

[0168] 1 H NMR (400MHz, CDCl3) δ8.77(d,J=1.9Hz,2H),8.40(d,J=2.0Hz,1H),8.16(d,J=1.9Hz,1H),3.98(d,J=1.2Hz,3H).

[0169] Step C: Synthesis of Intermediate Compound 3

[0170] According to the method described in Step G of Preparation Example 1, an intermediate compound 3 represented by the following formula can be obtained.

[0171]

[0172] Step D: Synthesis of intermediate compound 4

[0173] According to the method described in Step H of Preparation Example 1, an intermediate compound 4 represented by the following formula can be obtained.

[0174]

[0175] Step E: Synthesis of intermediate compound 5

[0176] Intermediate compound 4 (5mmol) is dissolved in dry toluene (35mL), and then cesium carbonate (7.5mmol) is added. The mixture is degassed with argon, and then tris (dibenzylideneacetone) dipalladium (0) (0.11mmol), 2,2'-bis (diphenylphosphino) -1,1'- dihydronaphthalene (0.2mmol) and 2,4- dimethoxybenzylamine (5mmol) are added. The mixture is stirred at 105 ° C (bath) under argon. The dark purple of the mixture becomes light yellow in 15min. After 20h, the reaction is cooled, and the solvent is removed under reduced pressure. The residue is purified on 50g of silica gel, and the eluent is 50% ethyl acetate in hexane. Intermediate compound 5 represented by the following formula can be obtained.

[0177]

[0178] Step F: Synthesis of intermediate compound 6

[0179] At ambient temperature, intermediate compound 5 (3.31mmol) is dissolved in dichloromethane (20mL), then trifluoroacetic acid (3.31mmol) is added. The orange-red solution is stirred for 5h at ambient temperature. Volatiles are removed under reduced pressure. The residue is alkalized with saturated NaHCO3 solution, and extracted with ethyl acetate. The organic phase is separated, dried and concentrated. The residue is purified on the silica gel of 40g, and the eluent is ethyl acetate, to provide the intermediate compound 6 represented by the following formula.

[0180]

[0181] Step G: Synthesis of intermediate compound 7

[0182] The intermediate compound 6 (1 mmol) was dissolved in 10 mL of acetic acid, and then sodium acetate (1 mmol) was added, and a 5 mL acetic acid solution of bromine (1.2 mmol) was added dropwise at room temperature. The reaction solution was then placed at the current temperature and continued to stir. After the reaction was completed, the reaction solution was quenched with sodium thiosulfate aqueous solution, then extracted with ethyl acetate and dried over anhydrous sodium sulfate. The residue was purified by column chromatography to obtain the intermediate compound 7 represented by the following formula.

[0183]

[0184] Step H: Synthesis of intermediate compound 8

[0185] The intermediate compound 7 (1 mmol) was dissolved in THF, and then cyclopropanecarbonyl chloride (1 mmol) and triethylamine (1.5 mmol) were added thereto, and the mixture was stirred at room temperature. After the reaction was completed, the mixture was purified by column chromatography to obtain the intermediate compound 8 represented by the following formula as a white solid.

[0186]

[0187] Intermediate compound 8

[0188] 1 H NMR(400MHz,Chloroform-d)δ9.44(d,J=1.6Hz,1H),8.75(d,J=2.0Hz,1H),8.30(d,J=2.0Hz,1H),8.12(s,1H),3.91(d,J=1 .6Hz,3H),3.81(q,J=7.5Hz,2H),1.74–1.68(m,1H),1.39(t,J=7.5Hz,3H),1.26–1.22(m,3H),1.06(dt,J=7.5,3.5Hz,2H).

[0189] Step I: Synthesis of intermediate compound 9

[0190] The intermediate compound 8 (1 mmol) was dissolved in THF (15 mL), and then Lawesson's reagent (1.5 mmol) was added and stirred under reflux. After the reaction was completed, the solvent was evaporated and the residue was purified by column chromatography to give the intermediate compound 9 represented by the following formula as a light yellow solid with a yield of 40%.

[0191]

[0192] Step J: Synthesis of target compound I-73

[0193] The intermediate compound 9 was dissolved in DMF, and then NaH was added and stirred in an oil bath at 80°C. After the reaction was completed, water was added thereto, and then extracted with ethyl acetate. The organic phase was dried over anhydrous sodium sulfate. Finally, it was purified by column chromatography to give the present compound I-73 represented by the following formula as a white solid, with a yield of 80%, mp 216-219°C.

[0194]

[0195] Compound I-73 of the present invention

[0196] 1 H NMR (400MHz, CDCl3) δ8.84(s,1H),8.77(d,J=1.9Hz,1H),8.34(d,J=2.1Hz,1H),3.86(s,3H),3.75(q, J=7.4Hz,2H),2.51(tt,J=8.1,5.3Hz,1H),1.46–1.41(m,4H),1.35(t,J=7.4Hz,3H).EI-MS:468[M+H] + .

[0197] Preparation Example 4:

[0198] Synthesis of target compound I-37

[0199] The intermediate compound 8 (1 mmol) was dissolved in 1,4-dioxane (15 mL), and then CuI (1.5 mmol) was added and stirred under reflux under a nitrogen atmosphere. After the reaction was completed, the solvent was evaporated and the residue was purified by column chromatography to give the present compound I-37 represented by the following formula as a white solid with a yield of 40%. mp224-227°C.

[0200]

[0201] Compound I-37 of the present invention

[0202] 1 H NMR (400MHz, CDCl3) δ8.77(dd,J=2.0,0.8Hz,1H),8.69(s,1H),8.31(d,J=2.0Hz,1H),3.87(s,3H),3.83(q,J=7.4 Hz,2H),2.35(tt,J=8.2,4.9Hz,1H),1.50–1.45(m,2H),1.42–1.39(m,2H),1.36(d,J=7.5Hz,3H).EI-MS:452[M+H] +

[0203] Preparation Example 5:

[0204] Synthesis of target compound I-109

[0205] Step A: Synthesis of intermediate compound 10

[0206] According to the method described in step 1 of preparation example 3, the substrate (1 mmol) was dissolved in THF (15 mL), and then Lawesson's reagent (1.5 mmol) was added and stirred under reflux. After the reaction was completed, the solvent was evaporated and the residue was purified by column chromatography to give the intermediate compound 10 represented by the following formula in a yield of 70%.

[0207]

[0208] Step B: Synthesis of target compound I-109

[0209] The intermediate compound 10 was dissolved in DMF, and then NaH was added and stirred in an oil bath at 80°C. After the reaction was completed, water was added thereto, and then extracted with ethyl acetate. The organic phase was dried over anhydrous sodium sulfate. Finally, it was purified by column chromatography to give the present compound I-109 represented by the following formula, with a yield of 85%. mp207-210°C.

[0210]

[0211] Compound I-109 of the present invention

[0212] 1 H NMR(400MHz, CDCl3)δ8.99(s,1H),8.79-8.73(m,2H),8.30(dd,J=8.8,1.9Hz,2H),3.94(s,3H),3.93-3.88(m,2H) ,2.52(tt,J=8.0,4.7Hz,1H),1.59-1.54(m,2H),1.47(dt,J=8.1,3.4Hz,2H),1.41-1.37(m,3H).EI-MS:468[M+H] + .

[0213] Similar to the examples and according to the above preparation method, the compound of the following formula (I) was synthesized:

[0214]

[0215] Table 2

[0216]

[0217]

[0218]

[0219]

[0220] The NMR data of the above preferred compounds are shown in Table 3:

[0221] Table 3

[0222]

[0223]

[0224] Biological tests:

[0225] This test example is used to illustrate the insecticidal activity inhibition (%) of the compound represented by the structure of formula (I) (dosage is 100 ppm).

[0226] Test Example 1: Activity against Myzus persicae (green peach aphid):

[0227] The roots of pea seedlings infested with a mixed age population of aphids were placed directly into an aqueous test solution prepared from a 10'000 ppm DMSO stock solution. After the seedlings were placed in the test solution for 6 days, the samples were evaluated for mortality.

[0228] The following compounds gave at least 90% mortality at an application rate of 100 ppm:

[0229] I-1, I-2, I-3, I-5, I-7, I-8, I-9, I-10, I-14, I-16, I-17, I-29, I-37, I-73, and I-109.

[0230] Test Example 2: Activity against Plutella xylostella:

[0231] 24-well microtiter plates with artificial diet were treated by pipetting with aqueous test solutions prepared from a 10'000 ppm DMSO stock solution. After drying, each plate was infested with L2 larvae (10 to 15 / well). After 5 days of infestation, these samples were evaluated for mortality and growth inhibition compared to untreated samples.

[0232] The following compounds gave an effect of at least 90% in at least one of the two categories (mortality or growth inhibition) at an application rate of 100 ppm:

[0233] I-1, I-2, I-3, I-5, I-7, I-8, I-9, I-10, I-14, I-16, I-17, I-29, I-37, I-73 and I-109.

[0234] Further the following compounds gave 100% mortality at an application rate of 4 ppm:

[0235] I-73 and I-109.

[0236] Test Example 3: Activity against armyworms:

[0237] The agar layer in a 24-well microtiter plate was treated by spraying with an aqueous test solution prepared from a 10'000 ppm DMSO stock solution. After drying, each plate was infested with L2 larvae (6 to 10 / well). Four days after infestation, these samples were evaluated for mortality and growth inhibition compared to untreated samples.

[0238] The following compounds gave an effect of at least 90% in at least one of the two categories (mortality or growth inhibition) at an application rate of 100 ppm:

[0239] I-1, I-2, I-3, I-5, I-7, I-8, I-9, I-10, I-14, I-16, I-17, I-29, I-37, I-73 and I-109.

[0240] Test Example 4: Activity against brown planthopper:

[0241] Cotton leaf disks were placed on agar in 24-well microtiter plates and sprayed with an aqueous test solution prepared from a 10,000 ppm DMSO stock solution. After drying, the leaf disks were infested with adult brown planthoppers. After incubation for 6 days, these samples were evaluated for mortality.

[0242] The following compounds gave at least 90% mortality at an application rate of 100 ppm:

[0243] I-1, I-2, I-3, I-5, I-7, I-8, I-9, I-10, I-14, I-16, I-17, I-29, I-37, I-73, I-100 and I-109.

[0244] Further the following compounds gave at least 95% mortality at an application rate of 45 ppm:

[0245] I-73, I-100 and I-109.

[0246] Test Example 5: Activity against Spodoptera exigua:

[0247] 24-well microtiter plates with artificial diet were treated by pipetting with aqueous test solutions prepared from a 10'000 ppm DMSO stock solution. After drying, each plate was infested with L2 larvae (10 to 15 / well). After 5 days of infestation, these samples were evaluated for mortality and growth inhibition compared to untreated samples.

[0248] The following compounds gave an effect of at least 90% in at least one of the two categories (mortality or growth inhibition) at an application rate of 100 ppm:

[0249] I-1, I-2, I-3, I-5, I-7, I-8, I-9, I-10, I-14, I-16, I-17, I-29, I-37, I-73, I-74, I-86 and I-109.

[0250] Further the following compounds gave 100% mortality at an application rate of 4 ppm:

[0251] I-73 and I-109.

[0252] Test Example 6: Activity against alfalfa sprouts:

[0253] The roots of pea seedlings infested with a mixed age population of aphids were placed directly into an aqueous test solution prepared from a 10'000 ppm DMSO stock solution. After the seedlings were placed in the test solution for 6 days, the samples were evaluated for mortality.

[0254] The following compounds gave at least 90% mortality at an application rate of 100 ppm:

[0255] I-1, I-2, I-3, I-5, I-7, I-8, I-9, I-10, I-14, I-16, I-17, I-29, I-37, I-73, I-74, I-86, I-88 and I-109.

[0256] Further the following compounds gave 100% mortality at an application rate of 4 ppm:

[0257] I-1, I-37, I-73, I-100 and I-109.

[0258] Test Example 7: Activity against Chilo suppressalis:

[0259] Take 5-6 rice seedlings of 3-4 cm in size, soak them in the prepared solution, dry them naturally in the shade, put them in a test tube, add 10 2nd instar larvae of Chilo suppressalis / tube, and place them in an observation room for feeding and observation. Use 0.1% Tween water as a blank control. Place them in an observation room at 25-27℃ for cultivation, investigate the results after 96 hours, and evaluate these samples for mortality.

[0260] The following compounds gave 100% mortality at an application rate of 5 ppm:

[0261] I-73 and I-109.

[0262] The above is only a preferred embodiment of the present invention. It should be pointed out that a person skilled in the art can make several modifications and improvements without departing from the inventive concept of the present invention, which all belong to the protection scope of the present invention.

Claims

1. A condensed ring compound containing a sulfur substituent, characterized in that: Compounds of formula (Ic): ; The R1 is selected from methyl or ethyl; The R is selected from cyclopropyl, isopropyl, cyclobutyl, vinyl, propenyl, butenyl, phenyl, cyanocyclopropyl, 4-fluorophenyl, 2-fluorophenyl, 3-fluorophenyl or 2,4-difluorophenyl.

2. A condensed ring compound containing a sulfur substituent, characterized in that: A compound of formula (Ia) or (Id): ; ; The R is selected from cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, phenyl, 4-fluorophenyl, 2-fluorophenyl, 2-methoxyphenyl, 2-trifluoromethylphenyl, 3-trifluoromethoxyphenyl, 3-fluorophenyl, 2,4-difluorophenyl, 2-thienyl, 3-pyridyl or 5-bromopyridyl.

3. The condensed ring compound containing sulfur substituents as claimed in claim 1, characterized in that: The R1 is selected from methyl; R is selected from cyclopropyl or 4-fluorophenyl.

4. The condensed ring compound containing sulfur substituents as claimed in claim 2, characterized in that: The R is selected from cyclopropyl or 4-fluorophenyl.

5. A method for preparing the sulfur-containing fused ring compound (Ia) according to claim 2, characterized in that The steps include: ; (1) stirring and refluxing the compound obtained by reacting the compound of formula (II) with the compound of formula (III) in acetic acid to obtain the compound of formula (IV); (2) contacting the compound represented by formula (IV) with ethanethiol under alkaline conditions to obtain the compound represented by formula (V); (3) reacting the compound represented by formula (V) with an oxidant to obtain the compound represented by formula (VI); (4) reacting the compound represented by formula (VI) with 2,4-dimethoxybenzylamine through a Buchwald coupling reaction to obtain a compound represented by formula (VII); (5) reacting the compound represented by formula (VII) with trifluoroacetic acid to obtain the compound represented by formula (VIII); (6) contacting the compound represented by formula (VIII) with a brominating agent to obtain a compound represented by formula (IX); (7) reacting the compound represented by formula (IX) with an acyl chloride in the presence of an acid binding agent to obtain a compound represented by formula (X); (8) reacting the compound represented by formula (X) with Lawesson's reagent to obtain a compound represented by formula (XI); (9) reacting the compound represented by formula (XI) in the presence of a base to obtain the final target compound represented by formula (Ia); 。 6. A method for preparing the sulfur-containing fused ring compound (Ic) according to claim 1, characterized in that The steps include: ; (1) reflux and stir the compound represented by formula (II) in acetic acid to obtain the compound represented by formula (III); (2) reacting the compound represented by formula (III) with ethanethiol in the presence of a base to obtain the compound represented by formula (IV); (3) The compound represented by formula (IV) is oxidized to obtain the compound represented by formula (V); (4) contacting the compound represented by formula (V) with a substituted amine in a solvent to obtain a compound represented by formula (VI); (5) dissolving the compound represented by formula (VI) in concentrated sulfuric acid, and then adding dilute nitric acid dropwise at low temperature to obtain the compound represented by formula (VII); (6) The compound represented by formula (VII) is reduced to obtain the compound represented by formula (VIII); (7) reacting the compound represented by formula (VIII) with a substituted acid chloride to obtain a compound represented by formula (IX); (8) reflux and stir the compound represented by formula (IX) in acetic acid to finally prepare the compound represented by formula (Ic); 。 7. A method for preparing the sulfur-containing fused ring compound (Id) according to claim 2, characterized in that The steps include: ; (1) contacting the compound of formula (V) prepared in (Ic) with aqueous ammonia in a solvent to prepare a compound represented by formula (X); (2) subjecting the compound represented by formula (X) to a bromination reaction in a solvent in the presence of a base to obtain a compound represented by formula (XI); (3) reacting the compound represented by formula (XI) with a substituted acid chloride to obtain a compound represented by formula (XII); (4) The compound represented by formula (XII) reacts with Lawesson's reagent to obtain the compound represented by formula (XIII); (5) The compound represented by formula (XIII) undergoes a cyclization reaction in the presence of a base to obtain compound (Id); 。 8. Use of a condensed ring compound containing a sulfur substituent represented by formula (I) as described in any one of items 1 to 4 in the preparation of an insecticide.

9. The use according to claim 8, characterized in that The insecticide is an insecticide for controlling Lepidoptera and / or Coleoptera.

10. The use according to claim 8, characterized in that The insecticide targets one or more of the following pests: brown planthopper, gray planthopper, whitefly, diamondback moth, armyworm, green peach aphid, and spider mite.

11. An insecticide, characterized in that The insecticide comprises the condensed ring compound containing sulfur substituents as claimed in any one of claims 1 to 4 and an auxiliary agent, and the concentration of the condensed ring compound containing sulfur substituents in the insecticide is 1 to 600 ppm.

12. The insecticide according to claim 11, characterized in that The concentration of the condensed ring compound containing a sulfur substituent in the pesticide is 4 to 100 ppm.